Organogenesis (NASDAQ:ORGO) Shares Down 3.6% - What's Next?Market Beat·Oct 24, 2026 at 04:20 AMORGO-3.57%
Organogenesis Holdings tumbles 8% during regular tradingMarket Movers·Oct 23, 2026 at 05:58 PMORGO-3.57%
HVAC and Automation Drive Industrial Sector Momentum Amid Regional DivergenceGlobal Report·Oct 20, 2026 at 10:15 AMSTRD+0.09%TT-0.87%
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot UlcersGlobeNewswire·Oct 12, 2026 at 08:10 PMORGO-3.57%
Organogenesis to report Q3 fiscal 2026 results, host conference callPUBT·Oct 12, 2026 at 08:06 PMORGO-3.57%
How Niche Tech Stocks Are Winning the Quiet Growth GameGlobal Report·Sep 29, 2026 at 10:17 AMBNAI+1.47%ESLT-1.06%
Truist Financial Sticks to Its Hold Rating for Organogenesis Holdings (ORGO)Tip Ranks·Aug 13, 2026 at 02:26 AMORGO-3.57%
The Tangible and the Abstract: What UWM’s Derivative Blowup Teaches Us About Business ModelsGlobal Report·Aug 11, 2026 at 10:13 AMORGO-3.57%VAC-3.21%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Aug 7, 2026 at 05:05 PMCVRX+3.65%EMBC-2.19%
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock PriceMarket Beat·Aug 7, 2026 at 01:36 PMORGO-3.57%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Aug 7, 2026 at 12:05 PMNTRA+0.64%QDEL+1.85%
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Sessionbenzinga_article·Aug 7, 2026 at 12:02 PMOUSTZ0.00%ARDX-3.75%
Organogenesis Q2 2026 net loss widens to $96.3 million; net revenue drops 58% to $42.8 million vs Q2 2025PUBT·Aug 6, 2026 at 08:44 PMORGO-3.57%
